# A literature review and novel theoretical approach on the optical properties of whole blood

- 4.2k Downloads
- 81 Citations

## Abstract

Optical property measurements on blood are influenced by a large variety of factors of both physical and methodological origin. The aim of this review is to list these factors of influence and to provide the reader with optical property spectra (250–2,500 nm) for whole blood that can be used in the practice of biomedical optics (tabulated in the appendix). Hereto, we perform a critical examination and selection of the available optical property spectra of blood in literature, from which we compile average spectra for the absorption coefficient (*μ* _{a}), scattering coefficient (*μ* _{s}) and scattering anisotropy (*g*). From this, we calculate the reduced scattering coefficient (*μ* _{s}′) and the effective attenuation coefficient (*μ* _{eff}). In the compilation of *μ* _{a} and *μ* _{s}, we incorporate the influences of absorption flattening and dependent scattering (i.e. spatial correlations between positions of red blood cells), respectively. For the influence of dependent scattering on *μ* _{s}, we present a novel, theoretically derived formula that can be used for practical rescaling of *μ* _{s} to other haematocrits. Since the measurement of the scattering properties of blood has been proven to be challenging, we apply an alternative, theoretical approach to calculate spectra for *μ* _{s} and *g*. Hereto, we combine Kramers–Kronig analysis with analytical scattering theory, extended with Percus–Yevick structure factors that take into account the effect of dependent scattering in whole blood. We argue that our calculated spectra may provide a better estimation for *μ* _{s} and *g* (and hence *μ* _{s}′ and *μ* _{eff}) than the compiled spectra from literature for wavelengths between 300 and 600 nm.

## Keywords

Blood Optical properties Spectroscopy Absorption coefficient Scattering coefficient Scattering anisotropy## Introduction

The interaction of light with blood plays an important role in optical diagnostics and therapeutics—for instance for the non-invasive assessment of blood composition [1] and the laser treatment of varicose veins [2]. Predictions on the accuracy and outcome of these optical methods can be obtained through simulation models of the light–blood interaction. The reliability of these models depends foremost on accurate knowledge of the optical properties of blood, which include the absorption coefficient *μ* _{a}, scattering coefficient *μ* _{s} and scattering anisotropy *g* that parameterizes the phase function *p*(*θ*). Dating back to as early as 1943 [3], many studies have focused on the quantitative assessment of these optical properties [4, 5, 6, 7, 8, 9, 10]. These studies demonstrated that optical property measurements on whole blood are challenging, due to the considerable light attenuation in undiluted blood. Although light attenuation is less in diluted samples, rescaling of the optical properties from these samples to whole blood introduces an additional challenge because the scattering properties of blood scale non-linearly as a function of red blood cell concentration (haematocrit) [10, 11, 12]. As a consequence, sample preparation, but also measurement method and conditions (e.g. blood flow [7, 13, 14, 15, 16]), influences the outcome of the optical property assessment considerably. In this review article, we will therefore provide an overview, interpretation and compilation of the available literature on the optical properties of blood in the visible and near-infrared wavelength range (250–2,500 nm). Our inclusion criteria are (1) publication of both quantitative and spectrally resolved data on *μ* _{a}, *μ* _{s} and *g* and (2) the use of human blood from healthy adults for sample preparation.

In part I (‘Methods’ and ‘Results’ sections) of this article, we focus on the absorption coefficient of whole blood. We compile an average *μ* _{a} spectrum for blood with a haematocrit of 45 % from rescaled spectra that are available in literature, while excluding outlier spectra. We also incorporate the effect of ‘absorption flattening’: the phenomenon that the absorption spectrum of a system of strongly absorbing particles (i.e. red blood cells in whole blood) is reduced compared to that of a suspension containing the same number of absorbing molecules in homogeneous dispersion (i.e. haemolysed blood).

The scattering properties of blood (*μ* _{s} and *g*) are considered in part II (‘Theoretical estimation of *μ* _{s} and *g* ’, ‘Methods’ and ‘Results’ sections) of this article. Given the difficulty in measuring the scattering properties of red blood cells, and the relative ease of measuring absorption spectra of the red blood cells’ contents, we previously proposed a computational approach based on a Kramers–Kronig analysis of the complex refractive index of haemoglobin [17]. We obtained estimates of red blood cell scattering by combining this approach with analytical scattering theory. Here, we extend this method using Percus–Yevick structure factors that take into account the spatial correlations between the positions of individual red blood cells in a whole blood medium. From this, we obtain calculated spectra of *μ* _{s} and *g* for oxygenized and deoxygenized blood. Moreover, we present a novel scaling relation for *μ* _{s} to different haematocrit values, which we use to theoretically verify a previously published empirical scaling relation [11]. We apply the novel scaling relation to rescale the available literature spectra for *μ* _{s} to a haematocrit of 45 %. From the rescaled spectra, we compile an average *μ* _{s} spectrum for whole blood. We also provide a compiled spectrum of the literature spectra of *g*. To provide the reader with reasonable means to estimate the scattering coefficient, we present an empirical power law for scattering coefficient versus wavelength (>700 nm). In addition, we provide spectra for the reduced scattering coefficient (*μ* _{s}′) and the effective attenuation coefficient (*μ* _{eff}), derived from both the compiled and calculated spectra of *μ* _{a}, *μ* _{s} and *g*.

The main results of this article are ready-to-use compiled spectra of *μ* _{a}, as well as both compiled and calculated spectra of *μ* _{s}, *μ* _{s}′, *μ* _{eff} and *g* for whole blood with a haematocrit of 45 %. For convenience, these spectra are tabulated in the Appendix of this article. Moreover, methods for scaling between different haematocrits are presented. We argue that our calculated spectra may provide a better estimation of the scattering properties of whole blood than the compiled spectra from literature for wavelengths <600 nm.

## Background

### Composition of human blood and its optical properties

Normal human blood consists of red blood cells (RBCs or erythrocytes, ±4,500 × 10^{3}/μL blood), white blood cells (leukocytes, ±8 × 10^{3}/μL blood), platelets (thrombocytes, ±300 × 10^{3}/μL blood) and blood plasma (containing water, electrolytes, plasma proteins, carbohydrates, lipids and various extracellular vesicles [18, 19]). The haematocrit (hct) is defined as the volume percentage of red blood cells in blood and on average amounts to 40 % for adult women and 45 % for adult men. Red blood cells are composed mainly of haemoglobin, with a concentration of ±350 g/L in a cell volume of ±90 fL. In healthy human adults, the average haemoglobin concentration in blood accounts for 140 g/L in women and 155 g/L in men [19].

Accounting for an absorption contribution of two to three orders of magnitude higher than the other blood components, red blood cells are by far the most dominant absorbing element in the blood in the wavelength range of 250–1,100 nm [20]. Practically, all light absorption by the red blood cells is due to haemoglobin, which exhibits specific absorption features for its various derivatives: bound to oxygen (oxyhaemoglobin, HbO_{2}), unbound to oxygen (deoxyhaemoglobin, Hb), bound to carbon monoxide (carboxyhaemoglobin), oxidized (methaemoglobin), fetal and more [4]. From these haemoglobin derivatives, oxyhaemoglobin and deoxyhaemoglobin are the most abundant types in healthy human adult blood. The oxygen saturation of blood is defined as the ratio of the HbO_{2} concentration to the total haemoglobin concentration, oxygen saturation (SO_{2}) = [HbO_{2}] / ([HbO_{2}] + [Hb]), and amounts to ∼97.5 % in arterial blood and ∼75 % in venous blood [19]. Of all blood particles, red blood cells also predominate the scattering of blood with two to three orders of magnitude, arising from the difference in refractive index between red blood cells and the surrounding blood plasma [20].

Without the presence of red blood cells, plasma absorption in the 250–1,100-nm region is dominated by various proteins, nutritive compounds and/or pharmaceuticals, while plasma scattering is dominated by proteins and platelets [20]. Under pathological conditions, the absorption contribution of certain plasma proteins can become significant even in the presence of red blood cells, e.g. the absorption of bilirubin around 460 nm for jaundiced patients [21].

In the wavelength range beyond 1,100 nm, blood absorption is dominated by the absorption of water [7, 9]. Only when water is removed from the blood, several absorption features due to the presence of haemoglobin, albumin and globulin can be identified as small absorption peaks between 1,690 and 2,400 nm [22].

### Factors influencing the optical properties of blood

Since red blood cells are the main contributor to the optical properties of blood, their volume percentage (i.e. haematocrit), haemoglobin concentration and oxygen saturation directly influence the absorption and scattering properties of blood. Whereas the absorption coefficient *μ* _{a} is proportional to the haematocrit, the scattering coefficient *μ* _{s} saturates for hct > 10 %, i.e. *μ* _{s}, is underestimated for high hct values with respect to a linear relationship between the two parameters [10]. Meinke et al. [10], in our opinion correctly, ascribed this saturation effect to a decrease of the mean distance between red blood cells, because it violates the assumption of independent single scattering. This group also reported non-linear deviations of *g* for hct > 10 %. See part II section of this paper for further discussion.

The scattering of blood is primarily caused by the complex refractive index mismatch between red blood cells and plasma. Although most measurements on the optical properties of blood are performed on blood samples where plasma has been replaced by saline/phosphate buffer, Meinke et al. [10, 20] measured that this affects the complex refractive index mismatch considerably, resulting in an overestimation of the scattering coefficient of 5.5–9.4 % with respect to red blood cells in plasma.

The principle of causality dictates that the real and imaginary parts of the complex refractive index are connected as expressed by the Kramers–Kronig relations. The imaginary part is proportional to the absorption coefficient, which in turn depends on the SO_{2}. Thus, the real part of the complex refractive index is also SO_{2} dependent and so are the scattering properties [9, 17]. This influence is most prominent in the visible wavelength region where differences in *μ* _{a} due to changes in SO_{2} are high, leading to deviations up to 15 % in *μ* _{s} and 12 % in *g* between fully oxygenated and fully deoxygenated blood [9].

Various sources have reported that the shear rate due to blood flow [7, 13, 14, 15, 16] and aggregate formation (e.g. rouleaux formation) [13, 23, 24] significantly influence the optical properties of blood due to non-Newtonian flow characteristics. Enejder et al. [13] measured a decrease in the absorption and reduced scattering of bovine blood of ∼3 % when increasing the average shear rate from 0 to 1,600 s^{−1}, as well as a decrease in reduced scattering of 4 % when randomly oriented red blood cells form aggregates.

Other reported factors of influence on the optical properties are osmolarity [7], temperature [25, 26], inter-person variability [9] and pathologic disorders such as sickle cell anemia [27]. A special case is that for adults versus fetuses, whose blood is composed of different types of haemoglobin (adult versus fetal haemoglobin) that exhibit slight variations in their absorption features [4].

### Measurement methods in literature

Most measurements on whole or diluted blood with intact red blood cells have been performed using single or double integrating sphere geometries. The resulting wavelength-dependent transmission and/or reflectance from a thin sample slab is analysed by inverse Monte Carlo models [6, 7, 8, 9, 10] or T-matrix computations [13] to obtain estimates for *μ* _{a}, *μ* _{s} and *g*. As is acknowledged by various sources [6, 7, 8], the assumed scattering phase function of blood in the inverse Monte Carlo analysis highly influences the inferred optical properties—especially *μ* _{s} and *g*. Although other measurement methods have been reported for optical property measurements on whole blood [28, 29], we did not encounter any studies that exploit these methods experimentally or the quantitative assessment of spectra of *μ* _{a}, *μ* _{s} and *g*.

In addition to whole blood measurements, non-scattering haemolysed blood has been investigated in conventional transmission measurement geometries to assess the *μ* _{a} of haemoglobin only [4, 5].

The refractive index of oxygenated haemoglobin solutions was determined by Friebel et al. [30] from measurements of the Fresnel reflection with an integrating sphere spectrometer. Complementing these measurements, Meinke et al. [10] measured the refractive index of plasma at four wavelengths using an Abbe refractometer, which yielded a Sellmeier equation for the visible wavelength range.

## Part I: the absorption coefficient of whole blood

### Methods

From the available optical property spectra in literature, we compiled the averaged spectra of *μ* _{a} for whole blood with a haematocrit of 45 %. Criteria for including optical property data were (1) publication of both absolute and spectrally resolved data on the optical properties and (2) the use of human blood from healthy adults for sample preparation. In case tabulated data were unavailable, the program *GetData Graph Digitizer* (v2.25.0.32) was used to obtain the digitized optical property spectra from the published graphs. The same criteria were applied for the inclusion and tabulation of literature spectra for *μ* _{s} and *g*, which will be considered in part II of this article.

#### Compiled literature spectrum of *μ* _{a}

*μ*

_{a}spectra were rescaled to a hct of 45 % or an equivalent tHb concentration of 150 g/L. Linear rescaling of

*μ*

_{a}spectra with respect to hct =

*X*%, i.e.

*μ*

_{a,hct}= 45 %

*=*(45/

*X*) and

*μ*

_{a,hct}=

*X*%, yields incorrect results if the absorption by the medium (water or plasma) cannot be neglected. This leads to an overestimation of the

*μ*

_{a}spectra at wavelengths where water absorption is substantial (

*λ*> 1,100 nm). We therefore perform a correction for the water absorption on the linearly rescaled

*μ*

_{a}spectra:

*μ*

_{a,hct = 45 %}is the rescaled

*μ*

_{a}spectrum to 45 % hct,

*μ*

_{a,hct = X%}is the literature

*μ*

_{a}spectrum at

*X*% hct and

*μ*

_{a,H2O}is the absorption coefficient of pure water, for which we used the spectrum from Hale et al. [31]. The water volume fraction [

*f*

_{blood}] in blood with hct =

*X*% is obtained using:

*f*

_{plasma}and

*f*

_{RBC}are the water volume fractions in blood plasma and red blood cells, respectively. In our analysis, we used

*f*

_{plasma}= 0.90 and

*f*

_{RBC}= 0.66, which correspond to normal physiological water concentrations in plasma and red blood cells [7]. Equations 1 and 2 show that the correct scaling between haematocrits at a given wavelength depends on the absorption coefficient of water at that wavelength.

*μ*

_{a}to that of whole blood. Citing Friebel et al. [8], the absorption flattening effect can be described as: ‘when light passes through a suspension of absorbing particles, such as blood, photons that do not encounter red blood cells pass unattenuated by absorption. As a consequence, the transmitted light intensity is higher than it would be if all the haemoglobin were uniformly dispersed in the solution’, Duysens [32] quantitatively described the reduction of the absorption coefficient obtained from a suspension of particles, with respect to that of a solution in which in the same amounts of absorbing molecules are homogeneously distributed. Following the method of Duysens, adapting only the terminology, we arrive at:

Where *μ* _{a,blood} and *μ* _{a,Hb} are the absorption coefficient of a blood sample and haemoglobin solution, respectively. The length *d* _{RBC} is a typical dimension of a red blood cell. In this derivation, it was assumed that the RBCs can be represented by cubes with volume equal to an RBC (*d* _{RBC} = ^{3}√90 μm). Following the same approach, Finlay and Foster [33] derived a more complex version of Eq. 3, valid for equivolumetric spherical particles. Since the difference between both forms is neglicable for the present parameters, we adhere to the much simpler form of Eq. 3 throughout this manuscript.

The compiled spectra of *μ* _{a} were obtained by averaging the rescaled spectra, with the exclusion of one outlier spectrum, as specified in the ‘Results’ section. The *μ* _{a} spectra for oxygenized (nine averages) and deoxygenized blood (three averages) were compiled separately.

### Results

#### Optical property spectra of human blood in literature

_{2}solutions are available from Zijlstra [4] and Prahl [5].

Literature on the optical properties of blood in the visible and near-infrared

Reference | Wavelength range (nm) | Method | Sample | Optical properties |
---|---|---|---|---|

Zijlstra et al. [4] | 450–800 | Transmission spectrophotometer | Hb solution from haemolysed RBCs (human); SO | |

Prahl [5] | 250–1,000 | Compiled data from Gratzer and Kollias | Hb solution from haemolysed RBCs; SO | |

Yaroslavsky et al. [6] | 700–1,200 | Double IS with inverse MC ( | Fresh heparinized whole blood (human); hct = 45–46 %, SO | |

Roggan et al. [7] | 400–2,500 | Double IS with inverse MC ( | Fresh RBCs (human) in phosphate buffer; hct = 5 %; SO | |

Friebel et al. [8] | 250–1,100 | IS with inverse MC ( | Fresh RBCs (human) in phosphate buffer; hct = 0.84, 42.1 %; SO | |

Friebel et al. [9] | 250–2,000 | IS with inverse MC ( | Fresh RBCs (human) in phosphate buffer; hct = 33.2 %; SO | |

Meinke et al. [10] | 250–1,100 | IS with inverse MC ( | Fresh RBCs (human) in phosphate buffer and saline solution/plasma various samples between hct = 0.84 and 42.1 % (shown in Figs. 1, 3 and 4: hct = 8.6, 41.2 %); SO | |

#### Compiled literature spectrum of *μ* _{a}

*μ*

_{a}spectra to hct = 45 % for oxygenized blood (SO

_{2}> 98 %) and deoxygenized blood (SO

_{2}= 0 %), respectively. For both oxygenized and deoxygenized blood, the rescaled

*μ*

_{a}spectra of Roggan et al. [7] consistently overestimate the other

*μ*

_{a}spectra for nearly all wavelengths up to one order of magnitude. Roggan et al. obtained this overestimation with respect to pure haemoglobin and water solutions also for the original sample haematocrit of 5 %, and ascribed the difference to an increased probability of absorption due to elongated photon paths, resulting from internal photon reflections inside the red blood cells. When rescaling these values to hct = 45 %, the overestimation is magnified to unrealistically high values for

*μ*

_{a}, in spite of the applied correction for the water absorption. We therefore excluded the

*μ*

_{a}spectra of Roggan et al. from the compiled spectra.

The spectra of haemolysed blood from Zijlstra [4] and Prahl [5] in Fig. 1a, b have been rescaled with the absorption flattening factor from Eq. 3. Unscaled, the *μ* _{a} spectrum of haemolised blood overestimates the absorption of both oxygenized and deoxygenized blood with approximately 10–20 % at the Soret band around 420 nm [5]. This difference has also been measured by Friebel et al. [8] when they compared their *μ* _{a} spectra from samples containing intact red blood cells to those containing haemolysed blood at exactly the same concentrations of haemoglobin. After correcting for the absorption flattening, the spectra are in good agreement with the absorption spectra from (whole) blood measurements.

The compiled *μ* _{a} spectrum of oxygenized blood is composed of the average of *N* = 9 spectra (Fig. 1c). Due to the difficulty to fully deoxygenize blood (high oxygen affinity of haemoglobin), fewer literature spectra are available for deoxygenized blood—resulting in a compiled *μ* _{a} spectrum of the average of *N* = 3 spectra for deoxygenized blood (Fig. 1c). Note that the data from Friebel et al. [9] are the only data contributing to the compiled spectrum beyond 1,200 nm for oxygenized blood and beyond 1,000 nm for deoxygenized blood (indicated by the dashed lines in Fig. 1c). The sudden jumps in the compiled spectra at 1,200 and 1,000 nm are caused by this transition of the average of multiple spectra to only one spectrum that differs slightly in amplitude (∼0.1 mm^{−1}) from the other spectra. We consider these jumps as artifacts of our compilation method, which can be ignored or smoothed when using these spectra in practice.

## Part II: the scattering properties of whole blood

The determination of the scattering properties of whole blood is extremely challenging because assumptions on the applied scattering phase function are of high influence and the scaling of diluted blood measurements to physiological haematocrit values is not straightforward (‘Background’ section). In our previous work, we therefore proposed to use a ‘forward’ approach to estimate the light scattering properties from accurate measurements of the absorption coefficient of haemoglobin solutions, followed by Kramers–Kronig (KK) analysis and application of light scattering theory [17]. We expand on this theoretical approach here to include dependent scattering effects.

In the first step, the complex refractive index is determined from the absorption coefficient of the contents of one red blood cell. This is used as input to scattering theory in the second step, accounting for inter-particle correlations due to high-volume fractions. This way, the theoretical scattering property spectra of blood can be calculated for any haematocrit at any wavelength. We use this theory to obtain calculated spectra for *μ* _{s} and *g* for whole blood with a haematocrit of 45 %.

For practical convenience, we proceed to average the scaling factors for *μ* _{s} over wavelength, which leads to a simple expression depending on haematocrit only. This novel scaling relation is then used to rescale literature spectra of *μ* _{s} to a haematocrit of 45 %, from which we compile an average spectrum.

Summarizing, in this part II of the article, we provide both calculated and compiled literature spectra for *μ* _{s} and *g*. From this, we calculate the reduced scattering coefficient *μ* _{s}′ and effective attenuation coefficient *μ* _{eff} for whole blood.

### Theoretical estimation of *μ* _{s} and *g*

#### Kramers–Kronig analysis

*κ*(

*ω*) of the complex refractive index

*m*(

*ω*) =

*n*(

*ω*) +

*iκ*(

*ω*) is related to the absorption coefficient

*μ*

_{a}through:

*c*is the speed of light and

*ω*is the angular frequency of the light. We use a subtractive KK equation [17, 35], so that:

*n*(

*ω*

_{0}) is the refractive index at some reference frequency

*ω*

_{0}, providing scaling of the calculated spectra.

*P*denotes the Cauchy principle value of the integral. Thus, knowledge of the absorption spectrum of the haemoglobin solution inside an RBC, in combination with a reference value for the refractive index, allows determination of the complex refractive index of the solution at any given frequency

*ω*(or wavelength

*λ*=

*c*/

*ω*).

#### Scattering properties of red blood cells

*I*

_{S}(

*θ*), per unit input intensity [36]. The scattering cross section [in square metre] is given by:

*k*is the wave number

*k*= 2

*π*/

*λ*. By normalization of

*I*

_{S}(

*θ*) on its 4

*π*solid-angle domain, the

*phase*function

*p*

_{P}(

*θ*) is obtained, which is parameterized by the expectation value of the cosine of the scattering angle, the scattering anisotropy

*g*[−]:

These scattering properties can be calculated if an appropriate theory is available to calculate *I* _{S}(*θ*). A common approach yielding reasonable agreement with experiment [37] is to describe the RBC as a sphere with an equivalent volume (90 μm^{3}, ‘Composition of human blood and its optical properties’ section) using Mie theory.

#### Scattering properties of whole blood

*N*randomly distributed, identical particles:

*E**denotes the complex conjugate of

*E*. The ensemble average runs over all possible arrangements of the particles in volume

*V*

_{T}(that contains all particle contributing to the signal).

*E*

_{s},

_{ n }denotes the scattered field amplitude of the

*n*th particle, located at r

_{ n.}The scattering vector q has magnitude |

*q*| = 2ksin(

*θ*/2).

*m = n*in the double sum define the light distribution when no interference between the scattered fields from different particles occurs, e.g. in a dilute medium. This condition is called ‘independent scattering’, and the total scattering cross section is simply

*N*times the scattering cross section of a single particle. The scattering coefficient (or density of the scattering cross section, [in meter]) follows from

*μ*

_{s}=

*σ*

_{s,TOTAL}/

*V*

_{T}or:

*V*

_{p}the particle volume.

*dependent scattering*in the biomedical optics literature, takes into account the

*m ≠ n*terms as well. Their contribution depends on the ordering in the arrangement of the particles, characterized by the radial distribution function

*G*(

*r*) which describes the probability of finding two particles spaced a difference

*r*apart. We may write [38, 39]:

*q*| = 2ksin(

*θ*/2). The term

*S*(

*θ*,hct) is called the structure factor, which thus allows to describe the angular scattering pattern from an ensemble of particles in terms of the scattered intensity pattern of a single particle, by applying a hct-dependent angular weighting of the scattered light. Combining Eq. 10 with Eq. 6, the scattering cross section for dependent scattering is found as:

*γ*(hct) is the haematocrit-dependent scaling factor between the scattering cross section for dependent scattering and independent scattering, and

*p*

_{P}(

*θ*) is the single-particle phase function. The scattering coefficient follows as:

Expressions for the phase function and scattering anisotropy for dependent scattering can also be derived using the same methods.

*G*(

*r*) is available (such as the Percus–Yevick model for non-deformable spheres used in this work). Scaling of the scattering coefficient between haematocrit values takes the following form for a blood medium:

#### Practical formula for haematocrit dependent scaling of *μ* _{s}

From the preceding analysis, it is clear that γ(hct)—the factor ultimately for non-linear scaling of the scattering coefficient with hct—can be a complicated function of wavelength because both *S*(*θ*,hct) and *p* _{P}(*θ*) are wavelength dependent. However, some practical expressions for γ(hct), depending on haematocrit only, have been presented in the literature.

*S*(

*θ*,hct) with

*S*(0,hct) and uses

*p*

_{P}(

*θ*) = (4

*π*)

^{−1}[40, 41, 42] so that the integral over the radial distribution function

*G*(

*r*) is evaluated at

*q*= 0 (or

*θ*= 0). Assuming scatterers of radius

*r*

_{p}that do not attract or repulse each other (‘gas model’), we have

*G*(

*r*) = 0 (

*r*≤

*r*

_{p});

*G*(

*r*) = 1 (

*r*>

*r*

_{p}). This leads to the simple expression:

*γ*(hct) at each wavelength using Eqs. 10 and 11 without restrictions on particle size, using the Mie phase function and the Percus–Yevick radial distribution function for non-deformable spheres. Averaging

*γ*(hct,

*λ*) over all wavelengths (250–2,000 nm) and both oxygenated forms and using a Levenberg–Marquardt non-linear least squares curve fitting procedure of

*γ*(hct) versus hct yields the following approximation:

Equations 17 and 18 are thus one of the main practical results of our work.

### Methods

#### Calculated spectra of *μ* _{s} and *g*

To compute the complex refractive index of an RBC’s contents, we model the RBC as a sphere (90 μm^{3}), containing a homogeneous solution of haemoglobin molecules. Hereto, we use the average of the oxygenized and deoxygenized *μ* _{a} spectra of haemolysed blood from Prahl and Zijlstra only (part I)—rescaled to the appropriate concentration (350 g/L per RBC; ‘Composition of human blood and its optical properties’ 2.1), but not corrected for absorption flattening. Using Eq. 4, the imaginary part of the complex refractive index is obtained. In the Kramers–Kronig analysis (Eq. 5), we use a reference measurement of the real part of the complex refractive index at 800 nm to scale the computed spectra. Details of this procedure can be found in our previous publication [17]. The obtained complex refractive index spectra of oxygenized and deoxygenized blood are then used as input for subsequent calculations.

To implement the theory of Eqs. 6–13, a consistent combination of scattering theory and structure factor is needed. Here, we use the Mie theory [36] to calculate the scattered intensity and scattering properties by approximating a red blood cell with an equivolumetric sphere (*r* = 2.78 μm). Mie calculations also require specification of the refractive index of the medium in which the scattering particles are suspended (i.e. plasma). The refractive index of plasma has been determined experimentally by Streekstra et al. [43] at 633 nm and by Meinke et al. [9] at 400, 500, 600 and 700 nm. Since no data is available on the entire required wavelength range (including the near-infrared), we approximate the refractive index of plasma by that of water [31] with an additional offset to achieve a value of 1.345 at 633 nm [43]. This agrees well with the values of Meinke et al. in the visible wavelength range.

We use the Percus–Yevick approximation [44], solved analytically by Wertheim [45], to calculate the structure factor of a suspension of non-deformable spheres. The exact descriptions of the Percus–Yevick radial distribution function can be found elsewhere, e.g. in Refs. [39, 45]. All calculations are performed using self-written routines in Labview. The Kramers–Kronig code is benchmarked against the routines available from Ref. [35]; the Mie code is benchmarked against the results from Prahl’s web-based Mie calculator [46].

#### Compiled literature spectra of *μ* _{s} and *g*

The available literature on optical property measurements of *μ* _{s} and *g* within our inclusion criteria (‘Methods’ section) is summarized in Table 1. All spectra were obtained using integrating sphere measurements in combination with inverse Monte Carlo simulations. Phase functions that were applied in the analysis of these literature spectra included the Henyey–Greenstein [6], the Gegenbauer–Kernel [7] and the Reynolds–McCormick phase function [8, 9, 10]; details can be found in the respective references. The Gegenbauer–Kernel and the Reynolds–McCormick phase functions cited in these publications are the same [34].

We rescaled the *μ* _{s} spectra from their original haematocrits (hct = *X*%) to a whole blood haematocrit of 45 % using Eqs. 13 and 17. From the rescaled spectra (*N* = 8), we compiled an average spectrum. The compiled spectrum of the anisotropy *g* was obtained from the average of the unscaled literature spectra of *g* (*N* = 9).

#### Scatter power analysis on *μ* _{s}

*μ*

_{a}is low with respect to

*μ*

_{s}. This power dependency can be described by:

*a*(in millimetre), scatter power

*b*(dimensionless), scattering coefficient

*μ*

_{s}(in millimetre), wavelength

*λ*and reference wavelength

*λ*

_{0}. To summarize the obtained

*μ*

_{s}spectra of blood, we determined the parameters

*a*and

*b*for both the calculated and compiled spectra. Hereto, we fitted Eq. 19 to the spectra beyond 700 nm with a least squares algorithm, using

*λ*

_{0}= 700 nm. Error estimations were obtained from the 95 % confidence intervals of the fits.

#### Reduced scattering *μ* _{s}′ and effective attenuation *μ* _{eff}

In general, studies that rely on the diffuse reflectance or transmittance of whole blood consider the reduced scattering coefficient *μ* _{s}′ = *μ* _{s}(1 − *g*) and the effective attenuation coefficient *μ* _{eff} = √[3*μ* _{a}(*μ* _{a} + *μ* _{s}′)], rather than the scattering coefficient *μ* _{s} and absorption coefficient *μ* _{a} only. Therefore, we present the compiled spectra of *μ* _{s}′ and *μ* _{eff}, using the compiled spectra from literature for *μ* _{a}, *μ* _{s} and *g*. We also present theory-derived spectra of *μ* _{s}′ and *μ* _{eff}, using the calculated spectra for *μ* _{a}, *μ* _{s} and *g*, with *μ* _{a} obtained as *μ* _{a} = *μ* _{ext} − *μ* _{s} with *μ* _{ext} the calculated extinction coefficient from Mie theory.

### Results

#### Calculated spectra of *μ* _{s} and *g*

*μ*

_{s}′, obtained from the calculated spectra of

*μ*

_{s}and

*g.*Results of the same calculations using the refractive index from Friebel et al. as input are also shown.

#### Compiled literature spectrum of *μ* _{s}

*μ*

_{s}at their original haematocrit values (all measured at SO

_{2}> 98 %). To rescale these spectra to hct = 45 %, we apply our Mie/Percus–Yevick scaling relation (Eqs. 13 and 17 combined), which has been displayed in Fig. 3b. For comparison, also a linear scaling relation (hct/

*X*) and the scaling relations of Twersky (Eqs. 13 and 14 combined and Eqs. 13 and 15 combined) [40, 41] and Steinke et al. (Eqs. 13 and 16 combined) [11] have been displayed. Figure 3c shows that the rescaled literature spectra using Eqs. 13 and 17 are much closer together in magnitude, compared to the unscaled spectra in Fig. 3a. The compiled average

*μ*

_{s}spectrum from the rescaled spectra (

*N*= 8) agrees well in shape and magnitude with the calculated

*μ*

_{s}spectra for those wavelengths where scattering dominates absorption (beyond 700 nm, Fig. 3d). Comparable to the compiled spectrum of

*μ*

_{a}, the jump in

*μ*

_{s}around 1,200 nm is an artifact of our compilation method, caused by the transition of the average of multiple spectra to fewer spectra.

#### Scatter power analysis on *μ* _{s}

The scatter power analysis (Eq. 19) resulted in *a* values of 82.5 ± 0.2 mm^{−1} (calculated *μ* _{s}, SO_{2} > 98 %), 72.2 ± 0.2 mm^{−1} (calculated *μ* _{s}, SO_{2} = 0 %) and 91.8 ± 0.6 mm^{−1} (compiled *μ* _{s}, SO_{2} > 98 %) using reference *λ* _{0} = 700 nm. The scatter power *b* values were 1.23 ± 0.005 (calculated *μ* _{s}, SO_{2} > 98 %), 1.22 ± 0.006 (calculated *μ* _{s}, SO_{2} > 0 %) and 1.19±0.012 (compiled *μ* _{s}, SO_{2} > 98 %).

#### Compiled literature spectrum of *g*

*g*on haematocrit has been reported (‘Background’ section), we do not perceive this effect in the literature spectra of

*g*at the original haematocrit values (Fig. 4a). The compiled spectrum for

*g*(Fig. 4b) is therefore obtained using all available, unscaled spectra (

*N*= 9). Note that the data from Roggan et al. [7] are the only data contributing to the compiled spectrum beyond 2,000 nm (indicated by the dashed line in Fig. 4b). The large oscillations in

*g*in this wavelength region are ascribed by Roggan et al. to ‘the small values of the measured quantities’, indicating a low signal-to-noise ratio for these wavelengths. Comparable to the compiled spectra of

*μ*

_{a}and

*μ*

_{s}, the jump in

*g*around 1,200 nm is an artifact of our compilation method, caused by the transition of the average of multiple spectra to fewer spectra. The compiled literature spectrum of

*g*agrees well in magnitude with the calculated spectra of

*g*for those wavelengths where scattering dominates absorption (beyond 700 nm).

#### Reduced scattering and effective attenuation

Figure 4c shows the calculated and compiled reduced scattering coefficient spectra *μ* _{s}′, which were obtained using the calculated and compiled spectra of *μ* _{s} and *g*, respectively. Similar to the spectra of *μ* _{s} and *g*, the calculated and compiled *μ* _{s}′ spectra agree well in magnitude for those wavelengths where scattering dominates absorption (beyond 700 nm).

Figure 4d shows the calculated and compiled effective attenuation coefficient spectra *μ* _{eff}. For the calculated spectrum of *μ* _{eff}, the absorption coefficient was calculated using Mie theory as the difference between the extinction coefficient and scattering coefficient (for both SO_{2} = 0 % and SO_{2} > 98 %). The compiled spectra were obtained using both the compiled spectrum for *μ* _{a} (part I) and the compiled spectrum for *μ* _{s}′ (only for SO_{2} > 98 %). The absorption coefficient dominates *μ* _{eff}. The excellent correspondence between the calculated and compiled spectra thus demonstrates that scattering theory is capable of including absorption flattening effects. The jumps in the 1,100–1,200 nm region and/or the oscillations beyond 2,000 nm in *μ* _{s}′ and *μ* _{eff} are caused by the compilation artifacts in *μ* _{a}, *μ* _{s} and *g* that have been explained above.

## Final remarks

### Tabulated data

In the Appendix of this article, we provide the tabulated data for the compiled spectra of *μ* _{a} (oxygenated and deoxygenated blood), *μ* _{s} and *g*. The table also includes the calculated spectra for *μ* _{s} and *g* (Kramers–Kronig/Percus–Yevick analysis for oxygenated and deoxygenated blood). All spectra are scaled to a haematocrit of 45 %. The data are presented with a resolution of 2 nm up to 600 nm and a resolution of 5 nm beyond 600 nm. From this, the calculated and compiled spectra for *μ* _{s}′ and *μ* _{eff} can easily be calculated. The full table can also be downloaded at our website www.biomedicalphysics.org.

### Discussion

#### Compilation of optical property spectra from literature

In this article, we provided an overview of the available literature on the spectra of the optical properties (*μ* _{a}, *μ* _{s} and *g*) of whole blood. Hereto, we included only data that present quantitative spectra of these properties and were measured on human blood or dilutions thereof. These restrictions limit the available data to the seven contributions as listed in Table 1, from which five contributions are obtained from (dilutions of) whole blood (*μ* _{a}, *μ* _{s} and *g*), and two contributions are obtained from haemolysed blood (*μ* _{a} only). It should also be noted that experimental studies on the optical properties are scarce for wavelengths beyond 1,100 nm, compared to the visible and near-infrared wavelength range (*λ* < 1,100 nm). Hence, our compiled spectra beyond 1,100 nm are composed of only one (*μ* _{a} and *μ* _{s}) or two (*g*) literature spectra, which makes them more susceptible to experimental or methodological errors than the compiled values for *λ* < 1,100 nm.

The compiled spectra for *μ* _{s} and *g* are largely dominated by the results from one research group (Roggan et al., Friebel et al. and Meinke et al. [7, 8, 9, 10]), with three out of four literature spectra for *μ* _{s} and eight out of nine literature spectra for *g*. All spectra were obtained using integrating sphere setups, in combination with inverse Monte Carlo simulations (IS/iMC, to translate the measured diffuse reflectance and/or collimated and diffuse transmittance to values of *μ* _{a}, *μ* _{s} and *g*). The results of the inverse procedure depend highly on the phase function that is used in the Monte Carlo simulations. For the research group of Roggan et al., Friebel et al. and Meinke et al., the preferred phase function is the Reynolds–McCormick (also called Gegenbauer–Kernel [34]) phase function. The authors argue that this phase function has better correspondence with their measurements than the often used Henyey−Greenstein phase function or the Mie phase function. This result can be understood considering Eq. 10, which shows that the ‘effective phase function’ of a blood medium is given by the single RBC phase function, multiplied with the concentration-dependent structure factor. An additional drawback of inverse Monte Carlo procedures is that all parameters are optimized independently, whereas, following from causality, a correlation exists between all optical properties (i.e. the Kramers−Kronig relations).

It would be beneficial to investigate the possibilities of other assessment techniques that avoid the methodological uncertainties (e.g. assumptions on phase function) that are associated with IS/iMC measurements. With optical coherence tomography (OCT), the non-diffusive component of the scattered light can be analysed, which facilitates quantification of the scattering properties, in addition to the absorption properties. With spectroscopic OCT [47, 48] and the closely related technique low-coherence spectroscopy (LCS), also the spectrally resolved optical properties can be quantified. LCS has been proven to give accurate estimations of *μ* _{a} and *μ* _{s} spectra in turbid media with relatively high attenuation (*μ* _{a} + *μ* _{s} up to 35 mm^{−1}) both in vitro [49, 50, 51] and in vivo [52] in the visible wavelength range. Alternatively, methods that rely on the analysis of diffuse scattering from whole blood may be combined with other analysis models than the regular inverse Monte Carlo simulations.

#### Absorption flattening in whole blood: rescaling *μ* _{a}

For the haemolysed blood spectra that contribute to the compiled spectrum of *μ* _{a} for whole blood, we take into account the absorption flattening effect. This effect involves the reduction of the absorption coefficient of a suspension of absorbing particles (i.e. blood containing RBCs), compared to a homogeneous solution containing the same number of absorbing molecules (i.e. haemolysed blood). The first theoretical assessment of absorption flattening originates from Duysens [32] for cubical-, spherical- and arbitrary-shaped particles. We use the cubical description (Eq. 3), since it only slightly deviates from Duysens’ more comprehensive spherical particle approximation (which was reintroduced by Finlay and Foster [33]). The analysis of Duysens assumes random placement of the absorbing particles, with no correlations between their positions (Poisson distribution; so that the spatial variance *σ* ^{2} of the number of particles equals the mean number *μ* of particles). Applying Beer’s law to each of the particles (and unit transmission for the ‘holes’) leads to the result of Eq. 3 upon averaging over all possible particle arrangements. If all particles were stacked together, *σ* ^{2} would be 0 (without changing *μ*) and the measured transmission would correspond to that of a homogeneous solution of the absorbing molecules—without absorption flattening. Thus, *σ* ^{2} ultimately determines the flattening effect. In a whole blood medium, possible correlations between the particle positions lead to an increase in *σ* ^{2}. This causes a further reduction in the measured absorption coefficient [53]. Interestingly, the increased *σ* ^{2} is determined by the volume integral of the radial distribution function *G*(*r*) [54], describing spatial arrangement that leads to dependent scattering effects (part II). This clearly emphasizes that the organization of a medium/tissue is reflected in all measurable optical properties. From a practical point of view, Duysens’ simple model of ‘cubic absorbers’ excellently scales data from haemoglobin solutions to the compiled absorption spectrum of blood.

The compartmentalization of haemoglobin in red blood cells causes the absorption flattening effect of blood absorption spectra compared to that of pure haemoglobin solutions. For techniques such as diffuse reflection spectroscopy, the same effect occurs on a larger scale because blood is not distributed homogeneously in tissue, but concentrated in vessels. Van Veen et al. [55] propose a correction factor introduced by Svaasand [56] that, interestingly, takes exactly the same form as Eq. 3 (but now with the vessel diameter as the length parameter instead of the diameter of the RBC), although it is derived in a completely different manner.

#### Dependent scattering in whole blood: rescaling *μ* _{s}

All literature spectra of *μ* _{s} were rescaled to a haematocrit of 45 % in the compilation of the average spectrum, while taking into account the effect of dependent scattering. Dependent scattering occurs when particles (i.e. RBCs) are closely spaced, or correlations exist between their positions. In that case, the phase relation between the fields scattered from different particles cannot be neglected. Therefore, the scattered fields should be added, rather than the scattered intensities. We choose a numerical, forward approach to assess the effect of dependent scattering, in which we calculate the scattering properties of blood using Mie theory (independent scattering) and Mie theory in combination with the Percus–Yevick radial distribution function *G*(*r*) (dependent scattering). This choice of theoretical descriptions essentially models blood as a high-concentration suspension of non-deformable spheres. This approach does not do full justice to the structural and rheological complexity of RBCs and blood. Future work on scattering formalisms, such as discrete dipole approximations [57] or models for *G*(*r*), can thus be employed using the same methodology.

A main practical result of our work is the scaling factor *γ*(hct) that scales the scattering coefficients of independent scattering to dependent scattering. The most cited form in the literature is *γ*(hct) = 1 − hct (Eq. 14), proposed by Twersky [40]. However, in the derivation of this approximation, it is assumed that the scatterers are small and no correlations exist between their spatial positions—which is likely invalid for whole blood. Twersky’s scaling factor has been found in better agreement with experiments compared to linear haematocrit scaling (e.g. *γ*(hct) = 1), but other theoretical and empirical forms have been proposed, most importantly Eqs. 15 and 16. In this work, we propose *γ*(hct) = (1 − hct)^{2} as a practical approximation for the exactly calculated values from Mie/Percus–Yevick theory (Eq. 17). The agreement with the empirical form of Steinke et al. [11] is excellent.

#### Theoretical estimation of *μ* _{s} and *g*

In addition to the compiled spectra from literature, we also *calculated* the spectra of *μ* _{s} and *g* for whole blood, using only the absorption spectrum of blood as an input. The main advantage of this ‘forward approach’ to calculate these optical properties is that complicated measurements on whole blood are replaced by relatively straightforward absorption measurements on non-scattering haemoglobin solutions. However, both our calculations and whole blood measurements with IS/iMC require assumptions in the analysis method (as discussed for IS/iMC in ‘Compilation of optical property spectra from literature’ section). In our method, a choice for scattering theory and radial distribution function must be made.

Our calculated spectra of the scattering coefficient *μ* _{s} are in reasonable agreement with the compiled spectra from literature (Fig. 3d). The order of magnitude is the same over the whole wavelength range that is considered, and all spectral features occur at the same wavelengths. The largest deviations are found in the wavelength range where the absorption of blood is strong compared to its scattering (250–600 nm). The same discrepancies are found in the spectrum of the scattering anisotropy *g* (Fig. 4b). Interestingly, these deviations are less prominent in the compounded parameters *μ* _{s}′ (reduced scattering coefficient, Fig. 4c) and *μ* _{eff} (effective scattering coefficient, Fig. 4d). Differences between the compiled and calculated spectra of *μ* _{s} and *g* may be caused either by false estimations of the phase function in the iMC analysis of the literature spectra and/or assumptions in our theoretical estimations.

In general, the input to Mie theory (or any other scattering formalism) is the complex refractive index *m*(*ω*) = *n*(*ω*) + *iκ*(*ω*) of the particle and of the suspending medium. In our calculations, its real part is obtained via Kramers–Kronig transformation of the imaginary part, which in turn is obtained from the absorption coefficient of haemoglobin (Eqs. 4 and 5). Meinke et al. [10] also calculated the scattering properties of blood using the Mie theory, using the experimentally determined values of the real part of the refractive index from haemoglobin solutions by Friebel et al. [30] (Fig. 2a). These measurements suggest that it can be expected that the refractive index of haemoglobin solutions will increase for wavelengths <300 nm, similar to the refractive index of plasma/water. This is not found in our calculations because haemoglobin absorption spectra (and thus of the imaginary part of the refractive index) are only available down to 250 nm. If these spectra would be available down to wavelengths overlapping with the water absorption in the UV, a similar increase in the refractive index is expected to be found. For this reason, we caution the use of our calculated spectra below 300 nm. However, the values for the refractive index of haemoglobin solutions from Friebel et al. [30] are on average 0.02 higher in magnitude than the values found through our Kramers−Kronig analysis (Fig. 2a), which Friebel et al. ascribed to sample preparation. Applying the experimentally determined refractive index of Friebel et al. in our analysis would therefore result in unrealistically high values for *μ* _{s} (Fig. 2b).

#### Choosing between the compiled and calculated spectra

Since the primary aim of this review is to provide the reader with a set of optical property spectra for whole blood that can be used in the practice of biomedical optics, the question remains which spectra the reader should choose from the provided results. For *μ* _{a}, we present only compiled literature spectra of oxygenated blood and deoxygenated whole blood (Fig. 1c). Hence, our logical advice is to use these compiled spectra. For *μ* _{s}, *g*, *μ* _{s}′ and *μ* _{eff} however, we present both the compiled and the calculated Kramers–Kronig/Percus–Yevick spectra (Figs. 3d and 4b–d, respectively). The compiled spectra, as well as the calculated spectra rely on individual assumptions in their analysis. At present, we cannot assess which method provides the most reliable results. It is therefore difficult to draw any solid conclusions on the choice between the compiled and calculated spectra for *μ* _{s}, *g*, *μ* _{s}′ and *μ* _{eff}.

In the wavelength below 600 nm, both the calculated and compiled experimental spectra of *all* optical properties show strong spectral fluctuations. This is expected, since the optical properties are strong functions of the complex refractive index. The real (*n)* and imaginary part (*κ*) of this quantity are interdependent on grounds of causality and as expressed by the Kramers–Kronig relations. The spectrum of *κ* can be easily obtained from the well-established absorption spectrum of haemoglobin solutions using Eq. 4. The spectrum of *n* is available through calculations (this work) and has been determined experimentally [30] as shown in Fig. 2a. Both methods show fluctuations in *n*(*λ*) around the large absorption peaks of haemoglobin with a modulation depth of 0.01–0.05 around their respective baseline values. To the best of our knowledge, no scattering theory applied to blood (cells) predicts the magnitude of the fluctuations in the compiled literature spectra of *μ* _{s} and particularly *g* using these input values. We hypothesize that this is largely due to the inverse Monte Carlo procedures as discussed in the ‘Compilation of optical property spectra from literature’ section. We therefore argue that our calculated spectra may provide a more consistent estimation of *μ* _{s}, *g*, *μ* _{s}′ and *μ* _{eff} for the wavelength range of 300–600 nm.

### Conclusion

In this article, we provided a critical review, compilation and calculation of the optical properties of whole blood (hct = 45 %). An important conclusion from our review study is that the optical properties of blood are influenced by a large variety of factors of both physical and methodological origin (‘Factors influencing the optical properties of blood’ section). One should always be aware of these factors when relying on literature spectra of *μ* _{a}, *μ* _{s} and *g* or when performing one’s own optical property measurements on blood.

For two important factors of influence—the effects of absorption flattening and dependent scattering—we provided practical formulas for rescaling literature spectra that have been obtained from haemolysed and diluted blood, respectively. Our theoretically derived formula for the influence of dependent scattering on *μ* _{s} is in good agreement with the previously reported empirical relation by Steinke et al. [11].

The main results of this article are the compiled spectra for the *μ* _{a} of oxygenized and deoxygenized whole blood (Fig. 1c) and both the compiled and calculated spectra for *μ* _{s} (Fig. 3d), *g* (Fig. 4b), *μ* _{s}′ (Fig. 4c) and *μ* _{eff} (Fig. 4d) of whole blood. We argue that our calculated spectra may provide a better estimation of *μ* _{s}, *g*, *μ* _{s}′ and *μ* _{eff} in the wavelength range of 300–600 nm. The compiled and/or calculated spectra of *μ* _{a}, *μ* _{s} and *g* have been tabulated in the Appendix of this article. From that, the spectra for *μ* _{s}′ and *μ* _{eff} can be easily calculated. With that, we hope that we have provided the reader with a set of optical property spectra for whole blood that can be used in the practice of biomedical optics.

## Notes

### Acknowledgments

N. Bosschaart is supported by the IOP Photonic Devices program managed by the Technology Foundation STW and AgentschapNL (IPD12020).

## References

- 1.McMurdy J, Jay G, Suner S, Crawford G (2009) Photonics-based in vivo total hemoglobin monitoring and clinical relevance. J Biophotonics 5:277–287CrossRefGoogle Scholar
- 2.Van den Bos R, Arends L, Kockaert M, Neumann M, Nijsten T (2009) Endovenous therapies of lower extremity varicosities: a meta-analysis. J Vasc Surg 49:230–239PubMedCrossRefGoogle Scholar
- 3.Horecker BL (1943) The absorption spectra of hemoglobin and its derivatives in the visible and near infra-red regions. J Biol Chem 148:173–183Google Scholar
- 4.Zijlstra WG, Buursma A, van Assendelft OW (2000) Visible and near infrared absorption spectra of human and animal haemoglobin. VSP, UtrechtGoogle Scholar
- 5.Data from Gratzer WB (Med. Res. Council Labs, Holly Hill, London) and Kollias N (Wellman Laboratories, Harvard Medical School, Boston) compiled and tabulated by Prahl S: http://omlc.ogi.edu/spectra/, accessed 26 March 2013
- 6.Yaroslavsky AN, Yaroslavsky IV, Goldbach T, Schwarzmaier HJ (1996) The optical properties of blood in the near infrared spectral range. Proc SPIE 2678:314–324CrossRefGoogle Scholar
- 7.Roggan A, Friebel M, Dorschel K, Hahn A, Muller G (1999) Optical properties of circulating human blood in the wavelength range 400–2500 nm. J Biomed Opt 4:36–46PubMedCrossRefGoogle Scholar
- 8.Friebel M, Roggan A, Muller G, Meinke M (2006) Determination of optical properties of human blood in the spectral range 250 to 1100 nm using Monte Carlo simulations with hematocrit-dependent effective scattering phase functions. J Biomed Opt 11:034021CrossRefGoogle Scholar
- 9.Friebel M, Helfmann J, Netz U, Meinke M (2009) Influence of oxygen saturation on the optical scattering properties of human red blood cells in the spectral range 250 to 2000 nm. J Biomed Opt 14:034001PubMedCrossRefGoogle Scholar
- 10.Meinke M, Muller G, Helfmann J, Friebel M (2007) Empirical model functions to calculate hematocrit-dependent optical properties of human blood. Appl Opt 46:1742–1753PubMedCrossRefGoogle Scholar
- 11.Steinke JM, Shepherd AP (1988) Diffuse model of the optical absorbance of whole blood. JOSA A 5:813–822CrossRefGoogle Scholar
- 12.Faber DJ, van Leeuwen TG (2009) Are quantitative attenuation measurements of blood by optical coherence tomography feasible? Opt Lett 34:1435–1437PubMedCrossRefGoogle Scholar
- 13.Enejder AMK, Swartling J, Aruna P, Andersson-Engels S (2003) Influence of cell shape and aggregate formation on the optical properties of flowing whole blood. Appl Opt 42:1384–1394PubMedCrossRefGoogle Scholar
- 14.Steenbergen W, Kolkman R, de Mul F (1999) Light-scattering properties of undiluted human blood subjected to simple shear. JOSA 16:2959–2967CrossRefGoogle Scholar
- 15.Friebel M, Helfmann J, Muller G, Meinke M (2007) Influence of shear rate on the optical properties of human blood in the spectral range 250 to 1100 nm. J Biomed Opt 12:054005PubMedCrossRefGoogle Scholar
- 16.Sakota D, Takatani S (2012) Quantitative analysis of optical properties of flowing blood using a photon-cell interactive Monte Carlo code: effects of red blood cells’ orientation on light scattering. J Biomed Opt 17:057007PubMedCrossRefGoogle Scholar
- 17.Faber DJ, Aalders MCG, Mik EG, Hooper BA, van Gemert MJC, van Leeuwen TG (2004) Oxygen saturation-dependent absorption and scattering of blood. Phys Rev Lett 93:028102PubMedCrossRefGoogle Scholar
- 18.Van der Pol E, Boïng AN, Harrison P, Sturk A, Nieuwland R (2012) Classification, functions and clinical relevance of extracellular vesicles. Pharmacol Rev 64:676–705PubMedCrossRefGoogle Scholar
- 19.Boulpaep EL (2009) Blood (chapter 18). In: Boron F, Boulpaep EL (eds) Medical physiology, 2nd edn. Saunders, Philadelphia, pp. 448–481Google Scholar
- 20.Meinke M, Muller G, Helfmann J, Friebel M (2007) Optical properties of platelets and blood plasma and their influence on the optical behavior of whole blood in the visible to near infrared wavelength range. J Biomed Opt 12:014024PubMedCrossRefGoogle Scholar
- 21.Bosschaart N, Kok JH, Newsum AM, Ouweneel DM, Mentink R, van Leeuwen TG, Aalders MCG (2012) Limitations and opportunities of transcutaneous bilirubin measurements. Pediatrics 129:689–694PubMedCrossRefGoogle Scholar
- 22.Edelman G, Manti V, Ruth SM, van Leeuwen T, Aalders M (2012) Identification and age estimation of blood stains on colored backgrounds by near infrared spectroscopy. Forensic Sci Int 220:239–244PubMedCrossRefGoogle Scholar
- 23.Tsinopoulos SV, Euripides JS, Polyzos D (2002) Light scattering by aggregated red blood cells. Appl Opt 41:1408–1417PubMedCrossRefGoogle Scholar
- 24.Lee VS, Tarassenko L (1991) Absorption and multiple scattering by suspensions of aligned red blood cells. JOSA 8:1135–1141CrossRefGoogle Scholar
- 25.Steinke JM, Sheperd AP (1992) Effects of temperature on optical absorbance spectra of oxy-, carboxy-, and deoxyhemoglobin. Clin Chem 38:1360–1364PubMedGoogle Scholar
- 26.Mordon S, Rochon P, Dhelin G, Lesage JC (2005) Dynamics of temperature dependent modifications of blood in the near-infrared. Lasers Surg Med 37:301–307PubMedCrossRefGoogle Scholar
- 27.Ergül Ö, Arslan-Ergül A, Gürel L (2010) Computational study of scattering from healthy and diseased red blood cells. J Biomed Opt 15:045004PubMedCrossRefGoogle Scholar
- 28.Serebrennikova YM, Smith JM, Huffman DE, Leparc GF, Garcia-Rubio LH (2008) Quantitative interpretations of visible-NIR reflectance spectra of blood. Opt Express 16:18215–18229PubMedCrossRefGoogle Scholar
- 29.Xu X, Lin J, Fu F (2011) Optical coherence tomography to investigate optical properties of blood during coagulation. J Biomed Opt 16:096002PubMedCrossRefGoogle Scholar
- 30.Friebel M, Meinke M (2006) Model function to calculate the refractive index of native hemoglobin in the wavelength range of 250–1100 nm dependent on concentration. Appl Opt 45:2838–2842PubMedCrossRefGoogle Scholar
- 31.Hale GM, Querry MR (1973) Optical constants of water in the 200-nm to 200-μm wavelength region. Appl Opt 12:555–563PubMedCrossRefGoogle Scholar
- 32.Duysens LMN (1956) The flattening of the absorption spectrum of suspensions, as compared to that of solutions. Biochim Biophys Acta 19:1–12PubMedCrossRefGoogle Scholar
- 33.Finlay JC, Foster TH (2004) Effect of pigment packaging on diffuse reflection spectroscopy of samples containing red blood cells. Opt Lett 29:965–967PubMedCrossRefGoogle Scholar
- 34.Reynolds LO, McCormick NJ (1980) Approximate two-parameter phase function for light scattering. JOSA 70:1206–1212CrossRefGoogle Scholar
- 35.Lucarni V, Saarinen JJ, Peiponen KE, Vartiainen EM (2005)
*Kramers-Kronig relations in optical materials research*. Springer Series in Optical Sciences 110, IXGoogle Scholar - 36.Van de Hulst HC (1981) Light scattering by small particles. Dovers, MineolaGoogle Scholar
- 37.Steinke JM, Shepard AP (1988) Comparison of Mie theory and the light scattering of red blood cells. Appl Opt 27:4027–4033PubMedCrossRefGoogle Scholar
- 38.Hespel L, Mainguy S, Greffet JJ (2001) Theoretical and experimental investigation of the extinction in a dense distribution of particles: nonlocal effects. JOSA A 18:3072–3076PubMedCrossRefGoogle Scholar
- 39.Khlebtsov NG, Maksimova IL, Tuchin VV, Wang LV (2002) Introduction to light scattering by biological objects. In: Tuchin VV (ed) Handbook of optical biomedical diagnostics. SPIE, Bellingham, pp 331–168Google Scholar
- 40.Twersky V (1970) Absorption and multiple scattering by biological suspensions. JOSA 60:1084–1093CrossRefGoogle Scholar
- 41.Twersky V (1978) Acoustic bulk parameters in distributions of pair-correlated scatterers. JASA 64:1710–1719CrossRefGoogle Scholar
- 42.Ishimaru A, Kuga Y (1982) Attenuation constant of coherent field in a dense distribution of particles. JOSA 72:1317–1320CrossRefGoogle Scholar
- 43.Streekstra GJ, Hoeksra AG, Nijhof EJ, Heethaar RM (1993) Light scattering by red blood cells in ektacytometry: Fraunhofer versus anomalous diffraction. Appl Opt 32:2266–2272PubMedCrossRefGoogle Scholar
- 44.Percus JK, Yevick GJ (1958) Analysis of classical statistical mechanics by means of collective coordinates. Phys Rev 110:1–13CrossRefGoogle Scholar
- 45.Wertheim MS (1963) Exact solution of the Percus-Yevick integral equation for hard spheres. Phys Rev Lett 10:321–323CrossRefGoogle Scholar
- 46.Prahl S (2013) Mie scattering calculator. omlc.ogi.edu/calc/mie_calc.html. Accessed 26 June 2013Google Scholar
- 47.Faber DJ, Mik EG, Aalders MC, van Leeuwen TG (2003) Light absorption of (oxy-)hemoglobin assessed by spectroscopic optical coherence tomography. Opt Lett 28:1436–1438PubMedCrossRefGoogle Scholar
- 48.Faber DJ, Mik EG, Aalders MC, van Leeuwen TG (2005) Toward assessment of blood oxygen saturation by spectroscopic optical coherence tomography. Opt Lett 30:1015–1017PubMedCrossRefGoogle Scholar
- 49.Bosschaart N, Aalders MCG, Faber DJ, Weda JJA, van Gemert MJC, van Leeuwen TG (2009) Quantitative measurements of absorption spectra in scattering media by low-coherence spectroscopy. Opt Lett 34:3746–3748PubMedCrossRefGoogle Scholar
- 50.Bosschaart N, Faber DJ, van Leeuwen TG, Aalders MCG (2011) Measurements of wavelength dependent scattering and backscattering coefficients by low-coherence spectroscopy. J Biomed Opt 16:030503PubMedCrossRefGoogle Scholar
- 51.Bosschaart N, Aalders MCG, van Leeuwen TG, Faber DJ (2012) Spectral domain detection in low-coherence spectroscopy. Biomed Opt Express 3:2263–2272PubMedCentralPubMedCrossRefGoogle Scholar
- 52.Bosschaart N, Faber DJ, van Leeuwen TG, Aalders MCG (2011) In vivo low-coherence spectroscopic measurements of local hemoglobin absorption spectra in human skin. J Biomed Opt 16:100504PubMedCrossRefGoogle Scholar
- 53.Kostinski AB (2001) On the extinction of radiation bya homogeneous but spatially correlated random medium. JOSA 18:1929–1933CrossRefGoogle Scholar
- 54.Twersky V (1975) Transparency of pair-correlated, random distributions of small scatterers, with applications to the cornea. JOSA 65:524–530CrossRefGoogle Scholar
- 55.Van Veen RLP, Verkruysse W, Sterenborg HJCM (2002) Diffuse-reflectance spectroscopy from 500 to 1060 nm by correction for inhomogeneously distributed absorbers. Opt Lett 27:246–248PubMedCrossRefGoogle Scholar
- 56.Svaasand LO, Fiskerstrand EJ, Kopstad G, Norvang LT, Svaasand EK, Nelson JS, Berns MW (1995) Therapeuatic response during pulsed laser treatment of port-wine stains: dependence on vessel diameter and depth in dermis. Lasers Med Sci 10:235–243CrossRefGoogle Scholar
- 57.Kalkman J, Bykov AV, Streekstra GJ, van Leeuwen TG (2012) Multiple scattering effects in Doppler optical coherence tomography of flowing blood. Phys Med Biol 57:1907–1917PubMedCrossRefGoogle Scholar

## Copyright information

**Open Access** This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.